Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1
Emily Berry1, Jennifer L Hardt, Jon Clardy
1Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Northwestern University, Chicago, IL 60611, USA.
Objective:
Endometrial cancer is the most common type of gynecologic cancer in the United States. In this study, we propose that a marine sponge compound, psammaplysene A (PsA) induces apoptosis in endometrial cancer cells through forced nuclear expression of FOXO1.
Methods:
Ishikawa and ECC1 cells were treated with varying doses of PsA. FOXO1 protein localization was observed using immunofluorescent staining of cells. The effects of PsA on cell viability and proliferation were assessed using a cell viability assay and a BrdU incorporation assay respectively. Cell cycle analysis was performed using flow cytometry. To assess the role of FOXO1 in PsA-induced apoptosis, FOXO1 was silenced in ECC1 cells using siRNA technique, and overexpressed in Ishikawa cells using an adenovirus containing FOXO1 cDNAs. Western blots were used to measure levels of FOXO1 and cleaved PARP proteins.
Results:
Treatment of both ECC1 and Ishikawa cells with PsA caused an increase in nuclear FOXO1 protein, a dramatic decrease in cell viability of approximately 5-fold (p<0.05) and minimal effect on proliferation. Furthermore, treatment of cells with PsA doubled the percentage of cells in the G2/M phase (p<0.05). PsA induced apoptosis in endometrial cancer cells. When FOXO1 was silenced in ECC1 cells and treated with PsA, the incidence of apoptosis decreased. In addition, overexpression of FOXO1 with PsA treatment increased apoptosis.
Conclusions:
Increasing nuclear FOXO1 function is important for the induction of apoptosis of endometrial cancer cells by PsA.
Insights
Marine sponge compound psammaplysene A (PsA) induces apoptosis in endometrial cancer cells by increasing nuclear FOXO1 expression. This finding offers a potential new therapeutic strategy for endometrial cancer treatment.
Area of Science:
- Gynecologic Oncology
- Molecular Biology
- Marine Natural Products Chemistry
Background:
- Endometrial cancer is the most common gynecologic malignancy in the US.
- Marine natural products are a source of novel therapeutic compounds.
- FOXO1 is a transcription factor involved in cell cycle regulation and apoptosis.
Purpose of the Study:
- To investigate the effect of psammaplysene A (PsA) on endometrial cancer cells.
- To determine the role of FOXO1 in PsA-induced apoptosis.
- To explore PsA as a potential therapeutic agent for endometrial cancer.
Main Methods:
- Ishikawa and ECC1 endometrial cancer cells were treated with varying doses of PsA.
- FOXO1 localization was assessed via immunofluorescence.
- Cell viability, proliferation, and cell cycle were analyzed.
- FOXO1 was manipulated (silenced or overexpressed) to study its role in PsA's effects.
Main Results:
- PsA treatment increased nuclear FOXO1 localization in both cell lines.
- PsA significantly decreased cell viability and induced apoptosis.
- PsA treatment led to an increase in G2/M phase cell cycle arrest.
- Silencing FOXO1 reduced PsA-induced apoptosis, while overexpression enhanced it.
Conclusions:
- PsA induces apoptosis in endometrial cancer cells.
- Nuclear expression of FOXO1 is crucial for PsA's apoptotic effect.
- PsA represents a promising compound for endometrial cancer therapy.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Apoptosis
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Caspases
